Prime Medicine, Inc. Common StockEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 3.02 USD | 6,94 USD | 2,67 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 7,117 USD | 6 | 2 | 4 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 180.617.451 | 23,76 | 7,65 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Prime Medicine, Inc. Common Stock
Mitarbeiter 146
Handelsplatz NASDAQ
Ticker Symbol PRME
IPO Datum 2022-10-20
Adresse 60 First Street, Cambridge, MA, United States, 02141
Webseite https://primemedicine.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Jeffrey D. Marrazzo M.B.A., M.P.A. | Executive Chair |
| 2 | Dr. Allan Reine M.D. | CEO & Director |
| 3 | Dr. Ann L. Lee Ph.D. | Chief Technical Officer |
| 4 | Dr. Andrew Anzalone M.D., Ph.D. | Co-Founder & Head of Platform |
| 5 | Dr. David R. Liu Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| 6 | Ms. Svetlana Makhni | Chief Financial Officer |
| 7 | Mr. Ryan E. Brown J.D. | Chief Legal Officer |
| 8 | Ms. Niamh Alix | Chief Human Resources Officer |
| 9 | Mr. Mohammed Asmal M.D., Ph.D. | Chief Medical Officer |
| 10 | Dr. Matthew J. Hawryluk M.B.A., Ph.D. | Chief Business Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Alphabet Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 5 | ARK Investment Management LLC | 0,00% | 0,00 Mio. USD |
| 6 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 9 | Casdin Capital, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 11 | Amova Asset Management Americas, Inc | 0,00% | 0,00 Mio. USD |
| 12 | Sumitomo Mitsui Trust Group Inc | 0,00% | 0,00 Mio. USD |
| 13 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 14 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 15 | ADAR1 Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 16 | MWG Caph Ltd | 0,00% | 0,00 Mio. USD |
| 17 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 18 | Redmile Group, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 20 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |